FDA-approved as Mounjaro (diabetes) and Zepbound (obesity)
Key Strengths: Curated peptide menu including BPC-157 and TB-500, compounded under strict USP 797 sterile protocols
Chandys hypothesis, that the rapid onset of the repairing processes induced by B12 shots might overwhelm the system and temporarily cause a worsening in symptoms, similar to the Jarisch-Herxheimer reaction in those treated for Lyme disease
National Association of Boards of Pharmacy
Reported Side Effects BPC-157 side effects reportedly include local redness/swelling, occasional dizziness or fatigue, and nausea (mainly in research applications)
Compare BPC-157 / TB-500 Blend by mechanism, evidence strength, expected timeline, side-effect profile, and whether its primary use case matches your goal